Multiple sclerosis (MS) is a challenging therapeutic area for clinical research without the right global CRO as your guide. Biorasi relies on smart trial design and project management to pivot quickly around variables in MS studies.
A comprehensive MS study strategy
Biorasi’s unconventional origins and nontraditional solutions include a legacy of neurology expertise to keep your trials on track and maintain control over MS studies:
- 24/7 insight into your clinical trials, from monitoring daily progress to planning future milestones.
- Our program management methodology focuses on optimizing your trials and meeting all MS study challenges — from recruitment to post-market strategy.
- Biorasi’s Neurology Center of Excellence combines decades CNS knowledge, MS clinical trial expertise, and decentralized strategies to ensure the most optimal study outcome.
What Went Wrong: Three Major Challenges to Alzheimer’s Disease Drug Discovery
Biorasi Completes Rare Nephrology Trial During COVID-19
WSCS 2020 Wrap Up: Biorasi joins the global dialogue for regenerative medicine